President Biden has announced that the 'open season' deadline for states to make everyone eligible to get the COVID-19 vaccine has been moved back to April 19. This is the latest adjustment to the vaccination timeline, reducing the wait for the general public from the original May 1 deadline. The updated deadline joins the revised goal to reach 200 million administered shots by Biden's 100th day in office.
A new study from McGill University has found that misinformation about the COVID-19 vaccine originating from the United States may be fueling conspiracy theories and other issues in Canada. Social media appears to be a driving factor in this cross-border information exchange, with Canadians who report frequent Twitter use experiencing high exposure to American news sources.
The first human tracheal transplant has been successfully completed, potentially paving the way to addressing medical conditions that contribute to thousands of deaths each year. The surgery, carried out by surgeons at Mount Sinai Hospital in New York City, took 18 hours to put a new windpipe into a patient who, until now, had been breathing through a tracheostomy.
Some extra-strength acetaminophen, a pain reliever sold under various brand names, has been recalled because the bottles weren't labeled properly. According to the recall notice from A-S Medication Solutions, LLM, the lack of the required OTC Drug Facts label may lead to some consumers taking the pain reliever without awareness of the potentially harmful effects.
Muscles put in a lot of work during daily life, suffering from wear and tear that is continually repaired to keep things functioning. A type of stem cells called skeletal muscle satellite cells play a key role in repairing muscle fibers when they're damaged by exercise or general activity. Sugar, according to a new study, may negatively impact these cells.
Apotex Corp has announced the voluntary recall of Guanfacine Extended-Release Tablets in 2mg strength over the possible risk of 'trace' contamination with an antipsychotic medication called Quetiapine Fumarate. The drugs were distributed in the US until mid-March, according to the company, which is notifying distributors, wholesalers, and others.
A new study from NSF International warns that many readily available supplements marketed for sports enhancement and weight loss contain experimental stimulants that haven't been tested in humans. The 'hidden pharmaceutical cocktail,' as the organization calls it, was identified in 17 OTC supplements sold in the US.
New COVID-19 travel recommendations by the US CDC have given the green light to fully vaccinated people to get back on planes or take other trips, though pandemic precautions should still be observed the agency warns. The new guidance from the US Centers for Disease Control and Prevention acknowledges that fully-vaccinated travelers are both less likely to get, and to spread, COVID-19.
The FDA has authorized multiple over-the-counter (OTC) COVID-19 tests that will enable asymptomatic people to be routinely screened for the coronavirus. The authorization covers multiple varieties of Abbott BinaxNOW, as well as the Quidel QuickVue At-Home OTC COVID-19 test and the BD Veritor System for Rapid Detection of SARS-CoV-2.
The Centers for Disease Control and Prevention has published its provisional mortality data on the leading causes of death in the US last year. Having claimed around 375,000 lives, the CDC says that COVID-19 was the third-highest cause of death in the United States in 2020, coming in third only to heart disease and cancer.
Eating and drinking high-sugar foods early in life may pave the way for learning and memory issues later in adulthood, according to a new study from the University of Southern California. The findings are particularly concerning in light of how many food products marketed at youth contain high levels of corn syrup and other sugars.
Months into the COVID-19 immunization rollout, new data from Pfizer suggests its vaccine has been 100-percent effective in preventing severe cases of coronavirus, with the effects of the drug lasting for more than six months. The new study built on Pfizer-BioNTech's original immunization research, following participants who had been injected with BNT162b2 to see who had gone on to catch COVID-19.